GLP-1 (SE) 10 mg

A single GLP-1 receptor agonist research peptide in exact 5 mg and 10 mg configurations.

Volume pricing

GLP-1 (SE) 10 mg1 vial

$119.90

View lot report

Available to verified research accountsExact-SKU documentationLaboratory research use only

The U.S. Food and Drug Administration has not evaluated statements on this site. Stack Research products are not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Exact SKU: STK-SM10
Lot: 1050
Laboratory: Accumark Labs
Report ID: WVED-FDT9
Sample received: 2026-03-02
Published: July 29, 2026

IdentityConforms

HPLC purity99.57% by HPLC

Measured content11.96 mg measured

Read the complete laboratory report

Open the PDF to read every page in the lot-specific report.

Open full report

About GLP-1 (SE)

The independent literature linked below uses the name semaglutide and examines GLP-1 receptor agonism in mechanistic animal research and controlled human studies. Those publications address their own study materials, populations, methods, and outcomes.

Stack Research supplies this product only for lawful in-vitro laboratory or analytical research. The independent literature linked on this page does not test this vial, and it provides no instructions for human or veterinary use.

Configuration and documentation

The configuration selected above controls the exact SKU, package image, and lot report shown on this page.

Research-use boundary

This page does not provide dosing, administration, treatment, diagnostic, or human-outcome guidance.

Product specifications

Available configurations: 5 mg / 10 mg
Composition: Single agonist research peptide
Documentation: Lot-specific COA published for this exact SKU.

Research & literature

The publications below discuss the named compound. Only the lot report above evaluates the Stack Research product.

A paper's findings do not establish the identity, purity, safety, or intended use of this product.

Search PubMed

Mechanism & research background

The selected literature uses the name semaglutide and examines GLP-1 receptor agonism. One paper studies distributed neural pathways in rodents, while the other reports long-term results from a controlled human trial.

The publications below discuss the named compound. Only the lot report above evaluates the Stack Research product.

Researchers should read each linked paper for its model, methods, and limits. The cited literature does not supply instructions for this product.

Frequently asked questions

Why does the literature section use the name semaglutide?

Semaglutide is the name used in the selected publications connected with this GLP-1 receptor agonist research topic. Those papers do not verify the identity or regulatory status of the Stack Research product.

Are the selected GLP-1 papers all the same type of evidence?

No. One is mechanistic animal research and one reports a controlled human trial. Model, study material, population, endpoints, and limitations must be evaluated separately.

Is a lot report available for the selected configuration?

A current lot report covers exact SKU STK-SM10, lot 1050, from Accumark Labs.

Does the selected configuration control the report shown?

Yes. Choosing a configuration updates every SKU-specific field and its linked lot report as one set.

Do the cited papers verify this vial?

No. The papers describe independent research. The lab-results section above contains the lot-specific evidence for this Stack Research product.

Do the studies cover the full GLP-1 (SE) formulation?

The publications below discuss the named compound. Only the lot report above evaluates the Stack Research product.

Can this page guide human or veterinary use?

No. Stack Research supplies this product for laboratory research only. This page provides no dosing, administration, treatment, or diagnostic guidance.

Can researchers open the original sources?

Yes. Each citation opens its PubMed record. The search link above opens the complete product-specific query.